All Content

AXIM Begins Clinical Trials with CBG Ointment

May 16, 2016

AXIM Biotechnologies, a Netherlands-based biotechnology company, announced that it would be entering clinical trials with its patent-pending cannabigerol (CBG) topical ointment formulation AX-1602, the company said in a May 16, 2016 press statement to BioPharm Inter


  • Twitter
  • Facebook
  • Linkedin
  • Rss